ID: ALA3417720

Max Phase: Preclinical

Molecular Formula: C14H24N2O4

Molecular Weight: 284.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(CC)OC1C=C(C(=O)O)CC(N)C1NC(C)=O

Standard InChI:  InChI=1S/C14H24N2O4/c1-4-10(5-2)20-12-7-9(14(18)19)6-11(15)13(12)16-8(3)17/h7,10-13H,4-6,15H2,1-3H3,(H,16,17)(H,18,19)

Standard InChI Key:  NENPYTRHICXVCS-UHFFFAOYSA-N

Associated Targets(non-human)

GABA transporter 1 233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.36Molecular Weight (Monoisotopic): 284.1736AlogP: 0.81#Rotatable Bonds: 6
Polar Surface Area: 101.65Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.19CX Basic pKa: 9.33CX LogP: -1.84CX LogD: -1.84
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.67Np Likeness Score: 1.43

References

1. Jurik A, Zdrazil B, Holy M, Stockner T, Sitte HH, Ecker GF..  (2015)  A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).,  58  (5): [PMID:25679268] [10.1021/jm5015428]

Source